BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2015
View Archived Issues
Integrin alpha-8 identified as a potential target/marker of MM relapse
Read More
Sylentis describes ORAI1-targeting siRNAs
Read More
CD28-directed therapy extends survival in macaque transplant model
Read More
Diaxonhit grants Felicitex license to lead series of small-molecule anticancer compounds
Read More
ORIG3N and LabCorp establish LifeCapsule strategic collaboration
Read More
MabSpace Biosciences and Jiangsu Hengrui Medicine collaborate on antibody development
Read More
Xeltis completes trial of bioabsorbable matrix in patients with one cardiac ventricle
Read More
Academics receive grants from U.K. antimicrobial resistance initiative
Read More
Ipsen to acquire OctreoPharm Sciences
Read More
Studies support rapastinel development for neuropathic pain
Read More
DA-6886: safety, tolerability and pharmacokinetics
Read More
Ampio Pharmaceuticals reports results from trial of Optina in DME
Read More
Afinitor extends progression-free survival in phase III trial in neuroendocrine tumors
Read More
Newly discovered inhibitor of HPV DNA amplification described
Read More
Isarna Therapeutics' ISTH-0036 receives E.U. orphan drug designation
Read More
Biodel starts phase IIb trial comparing rapid-acting insulin BIOD-531 to Humalog
Read More
Ono Pharmaceutical patents AXL kinase inhibitors
Read More
Bayer presents chymase inhibitors
Read More
Ube Industries discloses DNA topoisomerase inhibitors
Read More
Daiichi Sankyo develops phosphate transporter inhibitors
Read More
Lakewood-Amedex's bisphosphocins show activity against MDR-TB
Read More
Silencing SEMA3C and sunitinib show synergy in RCC
Read More
Otonomy reveals topline data from phase IIb trial of OTO-104 in Meniere's disease
Read More
ReNeuron's retinitis pigmentosa cell therapy receives FDA fast track designation
Read More
Visterra and A*STAR collaborate to develop VIS-513 for dengue virus infection
Read More
Lpath's iSONEP fails to meet endpoints in phase II wet AMD study
Read More
CytRx discloses updated interim results from phase II trial of aldoxorubicin in glioblastoma
Read More